DOKTER JOKE YSENBAERT
DOKTER JOKE YSENBAERT has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19k and a net result of €150k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 15% of 16132 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
| Equity | €19k |
| Net result | €150k |
| Better than sector | 15% |
| Active | 8 yrs |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 11.1% | 63.4% | |
| Net result | €150k | €62k | |
| Equity | €19k | €132k | |
| Gross operating margin | €193k | €116k | |
| Staff costs | €3k | €29k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €189k | €189k | €91k | €224k | €222k |
| Net profit | €150k | €148k | €69k | €169k | €163k |
| Cash flow | €152k | €150k | €70k | €172k | €170k |
| Staff costs | €3k | - | - | - | - |
| Income taxes | €42k | €45k | €24k | €51k | €51k |
| Dividends | €550k | €111k | €118k | €118k | €118k |
| Total assets | €174k | €436k | €544k | €562k | €516k |
| Equity | €19k | €430k | €392k | €441k | €390k |
| Debt | €155k | €6k | €151k | €121k | €127k |
| of which ≤ 1y | €155k | €5k | €151k | €121k | €126k |
| of which > 1y | - | - | - | - | - |
| Working capital | €15k | €425k | €386k | €440k | €386k |
| Employees (FTE) | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.10 | 94.32 | 3.56 | 4.64 | 4.06 |
| Quick ratio | 1.10 | 94.32 | 3.56 | 4.64 | 4.06 |
| Working capital ratio | 8.9% | 97.6% | 71.1% | 78.4% | 74.8% |
| Solvency | 11.1% | 98.7% | 72.2% | 78.5% | 75.5% |
| Debt / equity | 7.99 | 0.01 | 0.39 | 0.27 | 0.32 |
| Long-term debt ratio | - | - | - | - | - |
| Interest coverage | 185.85 | 120.17 | 74.76 | 202.27 | 132.93 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 86.2% | 34.0% | 12.8% | 30.0% | 31.6% |
| ROE | 774.9% | 34.4% | 17.7% | 38.3% | 41.9% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €174k | €436k | €544k | €562k | €516k |
| Fixed assets | 21/28 | €4k | €6k | €6k | €634 | €4k |
| Tangible fixed assets | 22/27 | €4k | €6k | €6k | €634 | €4k |
| Current assets | 29/58 | €170k | €430k | €537k | €561k | €512k |
| Amounts receivable within one year | 40/41 | €33k | €120k | €38k | €43k | €65k |
| Investments | 50/53 | €0 | €200k | - | - | - |
| Cash & bank | 54/58 | €122k | €108k | €499k | €517k | €447k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €174k | €436k | €544k | €562k | €516k |
| Equity | 10/15 | €19k | €430k | €392k | €441k | €390k |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k | €19k |
| Reserves | 13 | €0 | €410k | €373k | €422k | €371k |
| Accumulated profits (losses) | 14 | €737 | €889 | €389 | - | - |
| Amounts payable | 17/49 | €155k | €6k | €151k | €121k | €127k |
| Amounts payable within one year | 42/48 | €155k | €5k | €151k | €121k | €126k |
| Trade debts payable within one year | 44 | €1k | €1k | €161 | - | €594 |
| Income statement | ||||||
| Gross operating margin | 9900 | €193k | €193k | €91k | €225k | €223k |
| Operating result | 9901 | €187k | €187k | €90k | €221k | €216k |
| Financial income | 75 | €6k | €8k | €5k | €117 | €0 |
| Financial charges | 65 | €1k | €2k | €1k | €1k | €2k |
| Result before taxes | 9903 | €192k | €193k | €94k | €220k | €214k |
| Income taxes | 67/77 | €42k | €45k | €24k | €51k | €51k |
| Net result for the period | 9904 | €150k | €148k | €69k | €169k | €163k |
| Result to be appropriated | 9905 | €150k | €148k | €69k | €169k | €163k |
-
YSENBAERT, Jo Kaat EricDirectorState Gazette act 23455901 (13-12-2023)Current13-12-2023 → present
| NACE primary | Specialist medical practice(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 07-06-2018 |
| Status | Active |
| Postal code | 8800 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36302B1252/00F000 | Flanders | 1,060 m² | 1 · 192 m² | 16.3 m · 1 fl. |
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
13-12-2023 YSENBAERT, Jo Kaat Eric appointed as director
- YSENBAERT, Jo Kaat Eric, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "YSENBAERT, Jo Kaat Eric",
"address": "8800 Roeselare, Kasteelstraat 141/0012",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "6) de algemene vergadering heeft beslist de huidige bestuurder (gewezen zaakvoerder van de besloten vennootschap met beperkte aansprakelijkheid), hierna vermeld, ontslag te geven uit haar functie en is onmiddellijk overgegaan tot haar herbenoeming als niet-statutaire bestuurder voor een onbepaalde d",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0466.459.637",
"name": "MAREL",
"address": "8800 Roeselare, Izegemsestraat 52A",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "7) de algemene vergadering en de bestuurder hebben bijzondere volmacht verleend aan de naamloze vennootschap MAREL, met zetel te 8800 Roeselare, Izegemsestraat 52A, ondernemingsnummer 0466.459.637 rechtspersonenregister Gent, afdeling Kortrijk, alsook aan haar aangestelden en bedienden, die elk afzo",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Fran\u00E7ois Blontrock",
"firm_city": null,
"firm_name": "Blontrock \u0026 Vermeersch",
"office_city": "Brugge",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-13",
"filing_date": "2023-12-08",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-11-15",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0697.728.621",
"name_full": "DOKTER JOKE YSENBAERT",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Fran\u00E7ois Blontrock",
"org_rep_person_name": null,
"person_role_at_subject": "Notaris"
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal van de algemene vergadering",
"de geco\u00F6rdineerde tekst van de statuten"
],
"corrected_publication_numac": null
}| Legal nameNL | DOKTER JOKE YSENBAERT |